# Toho Lease

> Toho Lease is a VC fund in Fukushima backing Medical, Biotechnology and Pharmaceutical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Fukushima, Japan
- Total investments: 3
- Last investment: Jan 2020
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://toholease.jp/

Toho Lease is a VC fund in Fukushima focused on Medical and Biotechnology. Toho Lease provides leasing services for manufacturers and dealers.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Biotechnology | 1 | 33% |
| Pharmaceutical | 1 | 33% |
| Employee Benefits | 1 | 33% |
| Physical Security | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 2 | 67% |
| Corporate Round | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SecureSave | SecureSave provides a purpose-built emergency savings solution. Emergency savings are the foundation of financial wellness. Help your employees get started. Make an immediate impact on your team for a fraction of the cost of other workplace savings programs. |  | Corporate Round | Jan 08, 2020 |  |
| SECURE Japan | SECURE offers entry and exit management systems such as card readers, fingerprints, and facial recognition for offices, shops, and factories. They also provide the surveillance camera system by combining various devices and AI face recognition. |  |  | Jan 08, 2020 |  |
| Kringle Pharma | Kringle Pharma, Inc., a biopharmaceutical company, develops pharmaceutical products based on its research on hepatocyte growth factor (HGF) and NK4. Its HGF has the regenerative healing ability in regard to liver cells, as well as various cells and organs; and NK4 is a bi-functional molecule, which inhibits the invasion and metastasis of tumorcells as an HGF-antagonist, as well as possesses antiangiogenic activity. The company’s pipeline includes recombinant human HGF for the treatment of acute renal failure, skin ulcers, and CNS diseases; and recombinant human NK4 and NK4 gene drugs for cancer therapy. Kringle Pharma, Inc. was founded in 2001 and is based in Toyonaka, Japan. | $86.5M |  | Dec 05, 2016 |  |

3 of 3 investments shown.

## Co-investors
- [Brainpad](https://shizune.co/investors/profile/brainpad) — VC Fund, 2 deals together
- [i-nest capital](https://shizune.co/investors/profile/i-nest-capital) — VC Fund, 2 deals together
- [LAC](https://shizune.co/investors/profile/lac-co-ltd) — VC Fund, 2 deals together
- Morpho — VC Fund, 2 deals together
- [Property Agent](https://shizune.co/investors/profile/property-agent) — VC Fund, 2 deals together
- [Cyberdyne](https://shizune.co/investors/profile/cyberdyne) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Toho Lease invest in?

Toho Lease invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Funding Round and Corporate Round stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Toho Lease last invest?

The most recent investment recorded for Toho Lease closed in Jan 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co